보포스트 그룹
평가액
$7.986B
보유 종목
36
상위 10 비중
78.5%
보유 종목
36종목| 종목 | 보유수량 | 평가액 ▼ | 신고가 | 현재가 | ±신고 | 52주 | 비중 |
|---|---|---|---|---|---|---|---|
| CHENIERE ENERGY INC | 20,726,340 | $933.5M | $45.04 | $308.75 | +585.5% | $188.83 – $330.32 | 11.7% |
| SYNCHRONY FINANCIAL | 29,295,030 | $909.6M | $31.05 | $72.25 | +132.7% | $63.78 – $88.47 | 11.4% |
| VIASAT INC | 13,158,137 | $846.3M | $64.32 | $67.72 | +5.3% | $30.35 – $89.81 | 10.6% |
| QORVO INC | 9,000,000 | $636.1M | $70.68 | - | - | - | 8.0% |
| ALLERGAN PLC | 2,964,203 | $607.5M | $204.95 | - | - | - | 7.6% |
| COLONY NORTHSTAR INC | 47,905,461 | $601.7M | $12.56 | - | - | - | 7.5% |
| NEWS CORP | 19,137,469 | $504.8M | $26.38 | - | - | - | 6.3% |
| ANTERO RESOURCES CORP | 23,912,257 | $475.9M | $19.90 | $38.74 | +94.7% | $31.38 – $45.15 | 6.0% |
| PBF ENERGY INC | 15,724,175 | $434.1M | $27.61 | $71.28 | +158.2% | $26.02 – $91.17 | 5.4% |
| THERAVANCE BIOPHARMA INC | 9,309,168 | $318.7M | $34.24 | - | - | - | 4.0% |
| Dell Technologies Inc Class V | 3,052,459 | $235.7M | $77.21 | - | - | - | 3.0% |
| TWENTY FIRST CENTY FOX INC | 7,384,542 | $190.4M | $25.79 | - | - | - | 2.4% |
| KERYX BIOPHARMACEUTICALS INC | 25,791,678 | $183.1M | $7.10 | - | - | - | 2.3% |
| CARDINAL HEALTH INC | 2,530,000 | $169.3M | $66.92 | $281.10 | +320.1% | $182.50 – $281.10 | 2.1% |
| EXPRESS SCRIPTS HLDG CO | 2,556,891 | $161.9M | $63.32 | - | - | - | 2.0% |
| VERITIV CORP | 3,053,724 | $99.25M | $32.50 | - | - | - | 1.2% |
| ATARA BIOTHERAPEUTICS INC | 5,359,632 | $88.7M | $16.55 | - | - | - | 1.1% |
| MCKESSON CORP | 500,000 | $76.81M | $153.61 | $1,102.81 | +617.9% | $725.17 – $1,102.81 | 1.0% |
| PARATEK PHARMACEUTICALS INC | 2,394,498 | $60.1M | $25.10 | - | - | - | 0.8% |
| CHIPMOS TECHNOLOGIES INC | 3,048,295 | $58.89M | $19.32 | - | - | - | 0.7% |
| AMC ENTMT HLDGS INC | 3,565,361 | $52.41M | $14.70 | - | - | - | 0.7% |
| GTY TECHNOLOGY HOLDINGS INC | 4,400,000 | $46.02M | $10.46 | - | - | - | 0.6% |
| CENTENNIAL RESOURCE DEV INC | 2,407,153 | $42.09M | $17.48 | - | - | - | 0.5% |
| AVIS BUDGET GROUP | 1,036,900 | $39.46M | $38.06 | $125.45 | +229.6% | $87.69 – $713.97 | 0.5% |
| FORWARD PHARMA A/S | 6,463,265 | $39.23M | $6.07 | - | - | - | 0.5% |
| NOVAGOLD RES INC | 9,500,000 | $39.14M | $4.12 | $5.63 | +36.7% | $5.18 – $14.20 | 0.5% |
| CASCADIAN THERAPEUTICS INC | 8,721,079 | $35.67M | $4.09 | - | - | - | 0.4% |
| SABAN CAP ACQUISITION CORP | 2,326,500 | $23.38M | $10.05 | - | - | - | 0.3% |
| SILVER RUN ACQUISITION | 2,149,352 | $21.88M | $10.18 | - | - | - | 0.3% |
| SUNRUN INC | 2,848,082 | $15.81M | $5.55 | $8.63 | +55.5% | $6.89 – $21.41 | 0.2% |
| CENCORA INC | 188,850 | $15.63M | $82.75 | $359.03 | +333.9% | $252.74 – $374.75 | 0.2% |
| TRILOGY METALS INC NEW | 10,600,758 | $9.976M | $0.94 | $1.94 | +106.1% | $1.94 – $6.89 | 0.1% |
| OREXIGEN THERAPEUTICS INC | 2,226,839 | $4.721M | $2.12 | - | - | - | 0.1% |
| PIONEER NAT RES CO | 28,895 | $4.263M | $147.53 | - | - | - | 0.1% |
| SIMPLY GOOD FOODS CO | 1,035,146 | $2.458M | $2.37 | - | - | - | 0.0% |
| SABAN CAP ACQUISITION CORP | 1,163,250 | $1.373M | $1.18 | - | - | - | 0.0% |
37개 신고 항목을 36개 CUSIP으로 합산했습니다. 위임 운용사별로 나뉜 항목은 합산합니다.
13F는 롱 포지션만(롱옵션 포함, 숏·현금 제외)이며 분기말 기준입니다.
그 외 신고 항목
1건| 종목 | 종류 | 수량·원금 | 평가액 |
|---|---|---|---|
| THERAVANCE BIOPHARMA INC | 원금 표시(채권·노트) | 30,000,000 | $37.13M |
채권·노트(원금 표시)·선호주·예탁증권·값 없는 항목·옵션(콜·풋)은 참고로 싣되 평가액·종목수에는 세지 않습니다 — 주식수 기준·값 0 초과·옵션 제외·선호주 제외(Dataroma 방식). 옵션은 계약 수가 아니라 기초 주식수와 그 평가액으로 적습니다.